Key result
Myocarditis associated with COVID-19 infections and mRNA vaccines is a rare complication with a heterogeneous spectrum of clinical manifestations and outcomes.
Why the study?
Four main myocarditis presentations occur in the context of SARS-CoV-2, prompting a review of their clinical features and current management strategies.
Design
Review
Authors
Loading...
Clinicians should maintain awareness of this rare entity; review data leave open optimal risk stratification and long-term management.
This review summarizes the clinical presentations, pathogenesis, and management of four distinct types of SARS-CoV-2-associated myocarditis, highlighting that while rare, they require careful diagnostic evaluation and supportive care.
Lovell et al. (2022) conducted a review in COVID-19 and Myocarditis. COVID-19 infection and mRNA vaccines was evaluated. Myocarditis associated with COVID-19 infections and mRNA vaccines is a rare complication with a heterogeneous spectrum of clinical manifestations and outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: